Accuray is a privately held corporation dedicated to revolutionizing the
treatment of lesions and tumors anywhere in the body by the precise delivery
of high doses of radiation using the CyberKnife Robotic Radiosurgery System.
Through the development and marketing of the CyberKnife System, and
participation in ongoing clinical research at prominent hospitals, Accuray
and its customers are making radiosurgery a viable and accessible option for
cancer patients worldwide.